Gene expression analysis in combat veterans with and without post-traumatic stress disorder

Molecular Medicine Reports

Volumn 8, Issue 1, 2013, Pages 238-244

  Hollifield, Michael ^a,b   Moore, Dan ^c,d   Yount, Garret ^d  

^a Behavioral Health Research Center of the Southwest   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Gene expression; Mental health; Stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; DOPAMINE TRANSPORTER; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; NEUROPEPTIDE Y; SEROTONIN TRANSPORTER;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PILOT STUDY; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; QUALITY CONTROL; VETERAN;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; COMBAT DISORDERS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; QUALITY CONTROL; STRESS DISORDERS, POST-TRAUMATIC; VETERANS; YOUNG ADULT;

EID: 84878952759     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1475     Document Type: Article

References (40)

1. Koenen KC: Nature-nurture interplay: genetically informative designs contribute to understanding the effects of trauma and interpersonal violence. J Interpers Violence 20: 507-512, 2005.
2. Baker DG, Ekhator NN, Kasckow JW, et al: Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder. Am J Psychiatry 162: 992-994, 2005. (Pubitemid 40676214)
3. Bremner D, Vermetten E and Kelley ME: Cortisol, dehydroepiandrosterone, and estradiol measured over 24 hours in women with childhood sexual abuse-related posttraumatic stress disorder. J Nerv Ment Dis 195: 919-927, 2007. (Pubitemid 350125396)
4. Glover DA and Poland RE: Urinary cortisol and catecholamines in mothers of child cancer survivors with and without PTSD. Psychoneuroendocrinology 27: 805-819, 2002. (Pubitemid 35340808)
5. Mason JW, Giller EL, Kosten TR, Ostroff RB and Podd L: Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis 174: 145-149, 1986. (Pubitemid 16117404)
6. Rohleder N and Karl A: Role of endocrine and inflammatory alterations in comorbid somatic diseases of post-traumatic stress disorder. Minerva Endocrinol 31: 273-288, 2006.
7. Thaller V, Vrkljan M, Hotujac L and Thakore J: The potential role of hypocortisolism in the pathophysiology of PTSD and psoriasis. Coll Antropol 23: 611-619, 1999.
8. Yehuda R, Southwick SM, Nussbaum G, Wahby V, Giller EL Jr and Mason JW: Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis 178: 366-369, 1990. (Pubitemid 20203850)
9. Yehuda R, Giller EL Jr and Mason JW: Psychoneuroendocrine assessment of posttraumatic stress disorder: current progress and new directions. Prog Neuropsychopharmacol Biol Psychiatry 17: 541-550, 1993. (Pubitemid 23192596)
10. Yehuda R, Boisoneau D, Lowy MT and Giller EL Jr: Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 52: 583-593, 1995.
11. Rohleder D, Kiefer W and Petrich W: Quantitative analysis of serum and serum ultrafiltrate by means of Raman spectroscopy. Analyst 129: 906-911, 2004. (Pubitemid 39434026)
12. Blanchard EB, Hickling EJ, Buckley TC, Taylor AE, Vollmer A and Loos WR: Psychophysiology of posttraumatic stress disorder related to motor vehicle accidents: replication and extension. J Consult Clin Psychol 64: 742-751, 1996. (Pubitemid 26274536)
13. Yehuda R, Siever LJ, Teicher MH, et al: Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder. Biol Psychiatry 44: 56-63, 1998. (Pubitemid 28305542)
14. Bremner JD, Elzinga B, Schmahl C and Vermetten E: Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res 167: 171-186, 2008.
15. Lanius RA, Bluhm R, Lanius U and Pain C: A review of neuroimaging studies in PTSD: heterogeneity of response to symptom provocation. J Psychiatr Res 40: 709-729, 2006. (Pubitemid 44486243)
16. Shin LM, Wright CI, Cannistraro PA, Wedig MM, et al: A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry 62: 273-281, 2005 (Pubitemid 40990972)
17. Kolassa IT, Wienbruch C, Neuner F, et al: Altered oscillatory brain dynamics after repeated traumatic stress. BMC Psychiatry 7: 56, 2007.
18. Baker DG, Ekhator NN, Kasckow JW, et al: Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation 9: 209-217, 2001. (Pubitemid 34195779)
19. Maes M, Lin AH, Delmeire L, et al: Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 45: 833-839, 1999. (Pubitemid 29185473)
20. Spivak B, Shohat B, Mester R, et al: Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol Psychiatry 42: 345-348, 1997. (Pubitemid 27380968)
21. Tucker P, Masters B and Nawar O: Topiramate in the treatment of comorbid night eating syndrome and PTSD: a case study. Eat Disord 12: 75-78, 2004. (Pubitemid 38332041)
22. von Känel R, Hepp U, Kraemer B, et al: Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 41: 744-752, 2007. (Pubitemid 46659723)
23. Segman RH, Shefi N, Goltser-Dubner T, Friedman N, Kaminski N and Shalev AY: Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatry 10: 500-513, 2005. (Pubitemid 40646438)
24. Su TP, Zhang L, Chung MY, et al: Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders. J Psychiatr Res 43: 1078-1085, 2009.
25. Yehuda R, Cai G, Golier JA, et al: Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biol Psychiatry 66: 708-711, 2009.
26. Zieker J, Zieker D, Jatzko A, et al: Differential gene expression in peripheral blood of patients suffering from post-traumatic stress disorder. Mol Psychiatry 12: 116-118, 2007. (Pubitemid 46160977)
27. Koenen KC, De Vivo I, Rich-Edwards J, Smoller JW, Wright RJ and Purcell SM: Protocol for investigating genetic determinants of posttraumatic stress disorder in women from the Nurses' Health Study II. BMC Psychiatry 9: 29, 2009.
28. First MB, Spitzer RL, Gibbon M and Williams JBW (eds): Structured Clinical Interview for DSM-IV Axis I Disorders. American Psychiatric Press, Inc., Washington, DC, 2001.
29. Blake DD, Weathers FW, Nagy LM, et al: The development of a Clinician-Administered PTSD Scale. J Trauma Stress 8: 75-90, 1995.
30. Keane TM, Fairbank JA, Caddell JM, Zimering RT, Taylor KL and Mora CA: Clinical evaluation of a measure to assess combat exposure. Psychol Assess 1: 53-55, 1989.
31. Beck AT, Steer RA and Brown GK (eds): Manual for Beck Depression Inventory-II. Psychological Corporation, San Antonio, TX, 1996.
32. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH and Covi L: The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 19: 1-15, 1974.
33. Calcagno AM, Chewning KJ, Wu CP and Ambudkar SV: Plasma membrane calcium ATPase (PMCA4): a housekeeper for RT-PCR relative quantification of polytopic membrane proteins. BMC Mol Biol 7: 29, 2006.
34. Cohen J: A power primer. Psychol Bull 112: 155-159, 1992.
35. Laurell C, Wirta V, Nilsson P and Lundeberg J: Comparative analysis of a 3′ end tag PCR and a linear RNA amplification approach for microarray analysis. J Biotechnol 127: 638-646, 2007. (Pubitemid 46001468)
36. Kurimoto K, Yabuta Y, Ohinata Y and Saitou M: Global single-cell cDNA amplification to provide a template for representative high-density oligonucleotide microarray analysis. Nat Protoc 2: 739-752, 2007. (Pubitemid 47040035)
37. Kube DM, Savci-Heijink CD, Lamblin AF, et al: Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer. BMC Mol Biol 8: 25, 2007.
38. Bierhaus A, Schiekofer S, Schwaninger M, et al: Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50: 2792-2808, 2001. (Pubitemid 33733131)
39. Almasy L, Gur RC, Haack K, Cole SA, Calkins ME, Peralta JM, Hare E, Prasad K, Pogue-Geile MF, Nimgaonkar V and Gur RE: A genome screen for quantitative trait loci influencing schizophrenia and neurocognitive phenotypes. Am J Psychiatry 165: 1185-1192, 2008.
40. O'Donovan A, Sun B, Cole S, et al: Transcriptional control of monocyte gene expression in post-traumatic stress disorder. Dis Markers 30: 123-132, 2011.